Literature DB >> 27325402

[Social medicine assessment of patients with prostate cancer].

W Hoffmann1, W Vahlensieck2, D-H Zermann3.   

Abstract

Due to the increasing incidence of prostate cancer in social-medicine-relevant age groups, a correct subject-specific evaluation of the professional capacity of these patients with all stages of disease is required. A concluding assessment is only significant when based on concrete functional deficits.

Entities:  

Keywords:  Exhaustion, psychovegatative; Neoplasm metastasis; Progression risk; Rehabilitation; Social medicine

Mesh：

Year:  2016        PMID： 27325402     DOI： 10.1007/s00120-016-0139-9

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  18 in total

1.  [Not Available].

Authors:  Eva-Maria Kalusche-Bontemps; Monika Reuss-Borst; Pia Heußner; Ulf Seifart; Georgia Schilling; Jörn D Beck; Barbara Zimmer
Journal:  Oncol Res Treat       Date:  2015-07-27       Impact factor: 2.825

2.  Measurement of the tensile strength of the ventral abdominal wall in comparison with scar tissue.

Authors:  C Hollinsky; S Sandberg
Journal:  Clin Biomech (Bristol, Avon)       Date:  2006-08-10       Impact factor: 2.063

3.  Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer.

Authors:  Vahakn B Shahinian; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Arch Intern Med       Date:  2006-02-27

Review 4.  Pad weight testing in the evaluation of urinary incontinence.

Authors:  Jan Krhut; Roman Zachoval; Phillip P Smith; Peter F W M Rosier; Ladislav Valanský; Alois Martan; Peter Zvara
Journal:  Neurourol Urodyn       Date:  2013-06-24       Impact factor: 2.696

5.  Variations in morbidity after radical prostatectomy.

Authors:  Colin B Begg; Elyn R Riedel; Peter B Bach; Michael W Kattan; Deborah Schrag; Joan L Warren; Peter T Scardino
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

6.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

7.  Evolution and accomplishments of the Radiation Therapy Oncology Group.

Authors:  J D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-10-15       Impact factor: 7.038

8.  Return to work and sick leave after radical prostatectomy: a prospective clinical study.

Authors:  Sigrun Dahl; Eivind A S Steinsvik; Alv A Dahl; Jon Håvard Loge; Milada Cvancarova; Sophie D Fosså
Journal:  Acta Oncol       Date:  2013-11-06       Impact factor: 4.089

9.  P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.

Authors:  E Hammond; Brian A Berkey; Karen K Fu; Andy Trotti; Ruby F Meredith; Christopher U Jones; R Byhardt; E M Horwitz; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-01       Impact factor: 7.038

10.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

Authors:  Joerg Dietrich; Ruolan Han; Yin Yang; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.